Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism

References

1. ↵
   1. Jacobs B,
   2. Henke PK

   (2018) Evidence-based therapies for pharmacologic prevention and treatment of acute deep vein thrombosis and pulmonary embolism. Surg Clin North Am 98:239–253.

   OpenUrl
2. ↵
   1. Konstantinides SV,
   2. Torbicki A,
   3. Agnelli G,
   4. Danchin N,
   5. Fitzmaurice D,
   6. Galiè N,
   7. et al.

   (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35:3033–3073.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Sinha SK,
   2. Sachan M,
   3. Goel A,
   4. Singh K,
   5. Mishra V,
   6. Jha MJ,
   7. et al.

   (2017) Efficacy and safety of thrombolytic therapy in acute submassive pulmonary embolism:Follow-up study. J Clin Med Res 9:163–169.

   OpenUrl
4. ↵
   1. Chen H,
   2. Ren C,
   3. Chen H

   (2014) Thrombolysis versus anticoagulation for the initial treatment of moderate pulmonary embolism:a meta-analysis of randomized controlled trials. Respir Care 59:1880–1887.

   OpenUrlAbstract/FREE Full Text
5. ↵
   1. Canan Hasanoğlu H,
   2. Hezer H,
   3. Karalezli A,
   4. Argüder E,
   5. Kiliç H,
   6. Şentürk A,
   7. et al.

   (2014) Half-dose recombinant tissue plasminogen activator treatment in venous thromboembolism. J Investig Med 62:71–77.

   OpenUrlAbstract/FREE Full Text
6. 1. Sharifi M,
   2. Bay C,
   3. Schwartz F,
   4. Skrocki L

   (2014) Safe-dose thrombolysis plus rivaroxaban for moderate and severe pulmonary embolism:drip, drug, and discharge. Clin Cardiol 37:78–82.

   OpenUrlCrossRefPubMed
7. ↵
   1. Brandt K,
   2. McGinn K,
   3. Quedado J

   (2015) Low-dose systemic alteplase (tPA) for the treatment of pulmonary embolism. Ann Pharmacother 49:818–824.

   OpenUrlCrossRefPubMed
8. ↵
   1. Sista AK,
   2. Horowitz JM,
   3. Goldhaber SZ

   (2016) Four key questions surrounding thrombolytic therapy for submassive pulmonary embolism. Vasc Med 21:47–52.

   OpenUrlCrossRefPubMed
9. ↵
   1. Özkan M,
   2. Gündüz S,
   3. Biteker M,
   4. Astarcioglu MA,
   5. Çevik C,
   6. Kaynak E,
   7. et al.

   (2013) Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis:theTROIA trial. JACC Cardiovasc Imaging 6:206–216.

   OpenUrlAbstract/FREE Full Text
10. 1. Zhang Z,
    2. Zhai ZG,
    3. Liang LR,
    4. Liu FF,
    5. Yang YH,
    6. Wang C

    (2014) Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism:a systematic review and meta-analysis. Thromb Res 133:357–363.

    OpenUrlCrossRefPubMed
11. 1. Singh S,
    2. Houng A,
    3. Reed GL

    (2017) Releasing the brakes on the fibrinolytic system in pulmonary emboli:Unique effects of plasminogen activation and a2-antiplasmin inactivation. Circulation 135:1011–1020.

    OpenUrlAbstract/FREE Full Text
12. ↵
    1. Sharifi M,
    2. Bay C,
    3. Skrocki L,
    4. Rahimi F,
    5. Mehdipour M

    (2013) “MOPETT” Investigators. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol 111:273–277.

    OpenUrlCrossRefPubMed
13. ↵
    1. Kucher N,
    2. Boekstegers P,
    3. Müller OJ,
    4. Kupatt C,
    5. Beyer-Westendorf J,
    6. Heitzer T,
    7. et al.

    (2014) Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acuteintermediate-risk pulmonary embolism. Circulation 129:479–486.

    OpenUrlAbstract/FREE Full Text
14. ↵
    1. Ozcinar E,
    2. Cakici M,
    3. Dikmen Yaman N,
    4. Baran C,
    5. Aliyev A,
    6. Inan B,
    7. et al.

    (2017) Thrombus resolution and right ventricular functional recovery using ultrasound-accelerated thrombolysis in acute massive and submassive pulmonary embolism. Int Angiol 36:428–437.

    OpenUrl
15. ↵
    1. Meyer G,
    2. Vicaut E,
    3. Danays T,
    4. Agnelli G,
    5. Becattini C,
    6. Beyer-Westendorf J,
    7. et al.

    (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402–1411.

    OpenUrlCrossRefPubMedWeb of Science